Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001628280-15-000727
Filing Date
2015-02-13
Accepted
2015-02-13 15:53:16
Documents
1
Group Members
ALLIANZ GLOBAL INVESTORS TAIWAN LTDALLIANZ GLOBAL INVESTORS US LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A agi2014123113gprotalixbiot.htm SC 13G/A 92069
  Complete submission text file 0001628280-15-000727.txt   93875
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Subject) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-50118 | Film No.: 15613928
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1633 BROADWAY NEW YORK NY 10019
Business Address 1633 BROADWAY NEW YORK NY 10019 212-739-3000
Allianz Global Investors U.S. Holdings LLC (Filed by) CIK: 0001567940 (see all company filings)

EIN.: 330977088 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A